NF1‐mutant lung adenocarcinoma patients had inferior disease‐free survival (DFS), and overall survival (OS) compared to those with the EGFR-mutation (30), and downregulation of NF1 expression caused by truncating mutations was reported to confer resistance to EGFR-TKI in lung adenocarcinoma patients (31). The gene discussed is EGFR; the disease is lung adenocarcinoma.